HomeInsightsStock Comparison

Trident Lifeline Ltd vs Windlas Biotech Ltd Stock Comparison

Trident Lifeline Ltd vs Windlas Biotech Ltd Stock Comparison

Last Updated on: Jul 23, 2025

Key Highlights

  • The Latest Trading Price of Trident Lifeline Ltd is ₹ 270 as of 21 Jul 15:30.
  • The P/E Ratio of Trident Lifeline Ltd changed from 30.4 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe P/E Ratio of Windlas Biotech Ltd changed from 12 on March 2022 to 35.8 on March 2025 . This represents a CAGR of 31.42% over 4 years.
  • The Market Cap of Trident Lifeline Ltd changed from ₹ 182.95 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 3 yearsThe Market Cap of Windlas Biotech Ltd changed from ₹ 457.9 crore on March 2022 to ₹ 2176 crore on March 2025 . This represents a CAGR of 47.65% over 4 years.
  • The revenue of Trident Lifeline Ltd for the Mar '25 is ₹ 52.68 crore as compare to the Dec '24 revenue of ₹ 12.39 crore. This represent the growth of 325.18% The revenue of Windlas Biotech Ltd for the Mar '25 is ₹ 207.64 crore as compare to the Dec '24 revenue of ₹ 199.13 crore. This represent the growth of 4.27%.
  • The ebitda of Trident Lifeline Ltd for the Mar '25 is ₹ 10.02 crore as compare to the Dec '24 ebitda of ₹ 4.64 crore. This represent the growth of 115.95% The ebitda of Windlas Biotech Ltd for the Mar '25 is ₹ 30.49 crore as compare to the Dec '24 ebitda of ₹ 28.74 crore. This represent the growth of 6.09%.
  • The net profit of Trident Lifeline Ltd changed from ₹ 1.4 crore to ₹ 3.76 crore over 8 quarters. This represents a CAGR of 63.88% The net profit of Windlas Biotech Ltd changed from ₹ 12.07 crore to ₹ 16.28 crore over 8 quarters. This represents a CAGR of 16.14% .
  • The Dividend Payout of Trident Lifeline Ltd changed from 0 % on March 2020 to 0 % on March 2025 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Windlas Biotech Ltd changed from 19.79 % on March 2022 to 20.04 % on March 2025 . This represents a CAGR of 0.31% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Trident Lifeline Ltd

  • Trident Lifeline Limited was originally incorporated as Private Limited Company under the name 'Trident Lifeline Private Limited' on January 09, 2014.
  • Subsequently, Company converted into a Public Limited pursuant to Shareholders' Resolution on June 02, 2022 and name of Company was changed to 'Trident Lifeline Limited' on June 10, 2022.
  • The Company is engaged in business of marketing ethical pharmaceutical products in domestic as well as international market.
  • It is also engaged in distribution of pharmaceutical products through third party distribution network. Apart from these, the Company offer wide range of pharmaceutical formulations and products manufactured on contract manufacturing under loan license.
  • It operate in India as well as African, Latin American and East Indian Countries.

About Windlas Biotech Ltd

  • Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001.
  • The Company converted from a Private Limited Company to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
  • A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
  • TheIR manufacturing facilities are located at Dehradun in Uttarakhand.
  • It also has a sales force and distribution network spread across 14 states.

Trident Lifeline Ltd News Hub

News

Trident Lifeline to convene board meeting

Trident Lifeline will hold a meeting of the Board of Directors of the Company on 28 April ...

Read more

23 Apr 2025 10:16

News

Trident Lifeline to convene EGM

Trident Lifeline announced that an Extra Ordinary General Meeting (EGM) of the Company wil...

Read more

17 Apr 2025 16:03

News

Trident Lifeline jumps on collaboration with NIPER-A for Vorinostat, a rare cancer drug

According to an exchange filing, the alliance focuses on transferring the technology for V...

Read more

06 Mar 2025 11:28

News

Trident Lifeline to discuss results

Trident Lifeline will hold a meeting of the Board of Directors of the Company on 22 Januar...

Read more

17 Jan 2025 11:05

News

Trident Lifeline to announce Quarterly Result

Trident Lifeline will hold a meeting of the Board of Directors of the Company on 19 Octobe...

Read more

16 Oct 2024 12:46

News

Trident Lifeline to hold AGM

Trident Lifeline announced that the Annual General Meeting (AGM) of the company will be he...

Read more

09 Aug 2024 14:58

Windlas Biotech Ltd News Hub

News

Windlas Biotech to convene AGM

Windlas Biotech announced that the 24th Annual General Meeting(AGM) of the company will be...

Read more

04 Jul 2025 16:39

News

Windlas Biotech Ltd Spurts 3.25%

Windlas Biotech Ltd rose 3.25% today to trade at Rs 927. The BSE Healthcare index is up 0....

Read more

19 Jun 2025 09:30

News

Windlas Biotech Ltd Slips 4.88%, BSE Healthcare index Shed 1.03%

Windlas Biotech Ltd fell 4.88% today to trade at Rs 923. The BSE Healthcare index is down ...

Read more

23 May 2025 09:30

News

Board of Windlas Biotech recommends final dividend

Windlas Biotech announced that the Board of Directors of the Company at its meeting held o...

Read more

22 May 2025 21:08

News

Windlas Biotech to announce Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 22 May 202...

Read more

15 May 2025 12:29

News

Windlas Biotech receives affirmation in credit ratings from ICRA

Windlas Biotech has received reaffirmation in credit ratings from ICRA at ICRA A+; Stable/...

Read more

08 Apr 2025 15:08

SWOT Analysis Of Trident Lifeline Ltd

Strength

1

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

S

Weakness

3

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Trident Lifeline Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Windlas Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Trident Lifeline Ltd and Windlas Biotech Ltd

Which company has a larger market capitalization, Trident Lifeline Ltd or Windlas Biotech Ltd?

Market cap of Trident Lifeline Ltd is 310 Cr while Market cap of Windlas Biotech Ltd is 1,913 Cr

What are the key factors driving the stock performance of Trident Lifeline Ltd and Windlas Biotech Ltd?

The stock performance of Trident Lifeline Ltd and Windlas Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Trident Lifeline Ltd and Windlas Biotech Ltd?

As of July 23, 2025, the Trident Lifeline Ltd stock price is INR ₹270.0. On the other hand, Windlas Biotech Ltd stock price is INR ₹915.45.

How do dividend payouts of Trident Lifeline Ltd and Windlas Biotech Ltd compare?

To compare the dividend payouts of Trident Lifeline Ltd and Windlas Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions